Global Active Pharmaceutical Ingredients Market Professional Survey Report 2019

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs.
This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place.


The global Active Pharmaceutical Ingredients market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Active Pharmaceutical Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Active Pharmaceutical Ingredients market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Active Pharmaceutical Ingredients in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Active Pharmaceutical Ingredients manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck
Novartis
Pfizer
Roche
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Abbott Laboratories
Emcure Pharmaceuticals
Ipca Laboratories
Johnson Matthey
Guilin Pharmaceutical
Johnson & Johnson
Lonza Group

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Synthetic
Biotech

Segment by Application
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies